Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 831864, 6 pages
http://dx.doi.org/10.1155/2015/831864
Research Article

MHC Class I Chain-Related Gene A Diversity in Patients with Cutaneous Malignant Melanoma from Southeastern Spain

1Immunology Department, University Clinical Hospital Virgen de la Arrixaca, Carretera Madrid-Cartagena, El Palmar, 30120 Murcia, Spain
2Department of Social and Health Sciences, Area of Legal and Forensic Medicine, University of Murcia, 30100 Murcia, Spain
3Dermatology Department, University Clinical Hospital Virgen de la Arrixaca, Carretera Madrid-Cartagena, El Palmar, 30120 Murcia, Spain

Received 1 January 2015; Accepted 19 February 2015

Academic Editor: Giuseppe Murdaca

Copyright © 2015 José Antonio Campillo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. G. Casado, G. Pawelec, S. Morgado et al., “Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines,” Cancer Immunology, Immunotherapy, vol. 58, no. 9, pp. 1517–1526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. P. Lee, C. Yee, P. A. Savage et al., “Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients,” Nature Medicine, vol. 5, no. 6, pp. 677–685, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Morgado, B. Sanchez-Correa, J. G. Casado et al., “NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions,” Journal of Innate Immunity, vol. 3, no. 4, pp. 365–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Anichini, C. Vegetti, and R. Mortarini, “The paradox of T cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma,” Cancer Immunology, Immunotherapy, vol. 53, no. 10, pp. 855–864, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Groh, J. Wu, C. Yee, and T. Spies, “Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation,” Nature, vol. 419, no. 6908, pp. 734–738, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Konjević, K. Mirjačić Martinović, A. Vuletić et al., “Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients,” Clinical and Experimental Metastasis, vol. 24, no. 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. K. M. Martinovic, G. Konjević, N. Babović, and M. Inić, “The stage dependent changes in NK cell activity and the expression of activating and inhibitory NK cell receptors in melanoma patients,” Journal of Surgical Research, vol. 171, no. 2, pp. 637–649, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Pende, P. Rivera, S. Marcenaro et al., “Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity,” Cancer Research, vol. 62, no. 21, pp. 6178–6186, 2002. View at Google Scholar · View at Scopus
  9. L. Moretta, C. Bottino, D. Pende, R. Castriconi, M. C. Mingari, and A. Moretta, “Surface NK receptors and their ligands on tumor cells,” Seminars in Immunology, vol. 18, no. 3, pp. 151–158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Seliger, H. Abken, and S. Ferrone, “HLA-G and MIC expression in tumors and their role in anti-tumor immunity,” Trends in Immunology, vol. 24, no. 2, pp. 82–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. C. S. Vetter, V. Groh, P. T. Straten, T. Spies, E.-B. Bröcker, and J. C. Becker, “Expression of stress-induced MHC class I related chain molecules on human melanoma,” Journal of Investigative Dermatology, vol. 118, no. 4, pp. 600–605, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Carrega, G. Pezzino, P. Queirolo et al., “Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells,” PLoS ONE, vol. 4, no. 12, Article ID e8132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Pende, C. Cantoni, P. Rivera et al., “Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin,” European Journal of Immunology, vol. 31, no. 4, pp. 1076–1086, 2001. View at Google Scholar
  14. S. Bauer, V. Groh, J. Wu et al., “Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA,” Science, vol. 285, no. 5428, pp. 727–729, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Kasahara and S. Yoshida, “Immunogenetics of the NKG2D ligand gene family,” Immunogenetics, vol. 64, no. 12, pp. 855–867, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. D. H. Raulet, “Roles of the NKG2D immunoreceptor and its ligands,” Nature Reviews Immunology, vol. 3, no. 10, pp. 781–790, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Muro, R. López-Hernández, S. Llorente et al., “MICA molecules in disease and transplantation, a double-edged sword?” Current Immunology Reviews, vol. 8, no. 4, pp. 307–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. N. W. Zwirner, M. A. Fernández-Viña, and P. Stastny, “MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes,” Immunogenetics, vol. 47, no. 2, pp. 139–148, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. M. B. Fuertes, L. E. Rossi, C. M. Peralta, H. N. Cabrera, M. A. Allevato, and N. W. Zwirner, “Premalignant quiescent melanocytic nevi do not express the MHC class I chain-related protein A,” Medicina, vol. 71, no. 4, pp. 357–360, 2011. View at Google Scholar · View at Scopus
  20. S. Bahram, M. Bresnahan, D. E. Geraghty, and T. Spies, “A second lineage of mammalian major histocompatibility complex class I genes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 14, pp. 6259–6263, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Mizuki, M. Ota, M. Kimura et al., “Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 4, pp. 1298–1303, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. E. W. Petersdorf, K. B. Shuler, G. M. Longton, T. Spies, and J. A. Hansen, “Population study of allelic diversity in the human MHC class I-related MIC-A gene,” Immunogenetics, vol. 49, no. 7-8, pp. 605–612, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Steinle, P. Li, D. L. Morris et al., “Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family,” Immunogenetics, vol. 53, no. 4, pp. 279–287, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M.-K. Choy and M. E. Phipps, “MICA polymorphism: biology and importance in immunity and disease,” Trends in Molecular Medicine, vol. 16, no. 3, pp. 97–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. R. López-Hernández, M. Valdés, D. Lucas et al., “Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population,” Human Immunology, vol. 71, no. 5, pp. 512–514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Mizuki, A. Meguro, I. Tohnai, A. Gül, S. Ohno, and N. Mizuki, “Association of major histocompatibility complex class I chain-related gene A and HLA-B alleles with Behçet's disease in Turkey,” Japanese Journal of Ophthalmology, vol. 51, no. 6, pp. 431–436, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. G. García, F. Del Puerto, A. B. Pérez et al., “Association of MICA and MICB alleles with symptomatic dengue infection,” Human Immunology, vol. 72, no. 10, pp. 904–907, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Vallian, M. J. Rad, M. Tavallaei, and M. Tavassoli, “Correlation of major histocompatibility complex class I related A (MICA) polymorphism with the risk of developing breast cancer,” Medical Oncology, vol. 29, no. 1, pp. 5–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Boukouaci, M. Busson, R. P. de Latour et al., “MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease,” Blood, vol. 114, no. 25, pp. 5216–5224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Kennedy, A. Naipal, N. A. Gruis et al., “MICA gene polymorphism is not associated with an increased risk for skin cancer,” Journal of Investigative Dermatology, vol. 118, no. 4, pp. 686–691, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. J. A. W. Metzelaar-Blok, H. M. H. Hurks, A. Naipal et al., “Normal HLA class I, II, and MICA gene distribution in uveal melanoma,” Molecular Vision, vol. 11, pp. 1166–1172, 2005. View at Google Scholar · View at Scopus
  32. X. Gao, R. M. Single, P. Karacki, D. Marti, S. J. O'Brien, and M. Carrington, “Diversity of MICA and linkage disequilibrium with HLA-B in two north American populations,” Human Immunology, vol. 67, no. 3, pp. 152–158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Lucas, J. A. Campillo, R. López-Hernández et al., “Allelic diversity of MICA gene and MICA/HLA-B haplotypic variation in a population of the Murcia region in southeastern Spain,” Human Immunology, vol. 69, no. 10, pp. 655–660, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. M. Balch, J. E. Gershenwald, S.-J. Soong et al., “Final version of 2009 AJCC melanoma staging and classification,” Journal of Clinical Oncology, vol. 27, no. 36, pp. 6199–6206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Svejgaard and L. P. Ryder, “HLA and disease associations: detecting the strongest association,” Tissue Antigens, vol. 43, no. 1, pp. 18–27, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. E. H. Hughes, R. W. M. Collins, E. Kondeatis et al., “Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients,” Tissue Antigens, vol. 66, no. 3, pp. 195–199, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Muñoz-Saá, A. Cambra, L. Pallarés et al., “Allelic diversity and affinity variants of MICA are imbalanced in Spanish patients with Behçet's disease,” Scandinavian Journal of Immunology, vol. 64, no. 1, pp. 77–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Norris, E. Kondeatis, R. Collins et al., “Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism,” Gastroenterology, vol. 120, no. 6, pp. 1475–1482, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Douik, A. B. Chaaben, N. A. Romdhane et al., “Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population,” Human Immunology, vol. 70, no. 1, pp. 45–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. D. T. Bishop, F. Demenais, M. M. Iles et al., “Genome-wide association study identifies three loci associated with melanoma risk,” Nature Genetics, vol. 41, no. 8, pp. 920–925, 2009. View at Publisher · View at Google Scholar
  41. S. MacGregor, G. W. Montgomery, J. Z. Liu et al., “Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3,” Nature Genetics, vol. 43, no. 11, pp. 1114–1118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. K. M. Brown, S. MacGregor, G. W. Montgomery et al., “Common sequence variants on 20q11.22 confer melanoma susceptibility,” Nature Genetics, vol. 40, no. 7, pp. 838–840, 2008. View at Publisher · View at Google Scholar · View at Scopus